Jubilant Ingrevia Limited (LSI) to list on exchanges between 18-25th March-21. Net debt for Pharma and LSI stands at Rs20bn and Rs5bn. We assign Accumulate rating to Jubilant Pharmova v/s earlier Accumulate for Jubilant Life Sciences (Pharma and LSI). We increase our earnings estimate...